Author

Zhijie Ding 1

1 Janssen Scientific Affairs, LLC,Horsham,United States

HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: IBDQ IN THE SEAVUE STUDY

Christopher Gasink, Edward V. Loftus Jr, Timothy Hoops, James Izanec, Tony Ma, Zhijie Ding, Erik Muser, Peter Irving, Matthieu Allez, William J. Sandborn, Remo Panaccione, Silvio Danese

HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: PROMIS-29 IN THE SEAVUE STUDY

Matthieu Allez, James D. Lewis, Peter Irving, Timothy Hoops, James Izanec, Tony Ma, Zhijie Ding, Erik Muser, Christopher Gasink, Remo Panaccione, Edward V. Loftus Jr, Bruce E. Sands, Silvio Danese

Item 1 - 2 / 2
1